Barnali Pramanik
- Co-authors
- Chong K. JueThomas H. RudeDena L. ToffalettiJohn R. ThompsonXiling YuanCameron DouglasMyra B. KurtzWeili Li
- Topics
- Lung Cancer Treatments and Mutations (3 papers)Radiopharmaceutical Chemistry and Applications (2 papers)Cancer-related Molecular Pathways (2 papers)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Barnali Pramanik
11 papers receiving 466 citations
Peers
Comparison fields: 5 of 67
- Molecular Biology 228
- Oncology 120
- Epidemiology 100
- Infectious Diseases 96
- Plant Science 72
Countries citing papers authored by Barnali Pramanik
This map shows the geographic impact of Barnali Pramanik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barnali Pramanik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barnali Pramanik more than expected).
Fields of papers citing papers by Barnali Pramanik
This network shows the impact of papers produced by Barnali Pramanik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barnali Pramanik. The network helps show where Barnali Pramanik may publish in the future.
Co-authorship network of co-authors of Barnali Pramanik
This figure shows the co-authorship network connecting the top 25 collaborators of Barnali Pramanik. A scholar is included among the top collaborators of Barnali Pramanik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barnali Pramanik. Barnali Pramanik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 45 | |
| 3 | 1 | |
| 4 | 61 | |
| 5 | 2 | |
| 6 | 67 | |
| 7 | A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer. | 72 |
| 8 | 4 | |
| 9 | Phase I trial of the farnesyl protein transferase (FPTASE) inhibitor L-778123 in combination with radiotherapy | 1 |
| 10 | 144 | |
| 11 | 75 |
About Barnali Pramanik
Barnali Pramanik is a scholar working on Oncology, Biochemistry and Cancer Research, having authored 11 papers that have together received 475 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Infectious Diseases (96 citations), Oncology (120 citations) and Pharmacology (65 citations). Barnali Pramanik has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Chong K. Jue, Thomas H. Rude, Dena L. Toffaletti, John R. Thompson, Xiling Yuan, Cameron Douglas, Myra B. Kurtz, Weili Li, John R. Perfect and Debbie Smith. Their work appears in journals such as Journal of Clinical Oncology, Diabetes and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.